Actis, an early backer of Pine Labs, sold 2.39 crore shares in a block deal worth ₹371 crore on June 24. The shares were offloaded at ₹155.17 each through Actis Pine Labs Investment Holdings, according to BSE bulk deal data. This marks the second stake sale by Actis within a week, following a ₹151.6 crore sale on June 19.
The recent sale saw Axis Mutual Fund purchase 96.15 lakh shares for ₹148 crore. Actis initially acquired its stake in Pine Labs in 2018 during an $82 million funding round. The investor had also sold shares worth ₹194.7 crore during Pine Labs’ IPO in November 2025. As of the March quarter, Actis held 5.26 crore shares, representing a 4.58% stake in the fintech company, per Pine Labs’ shareholding data.
The bulk deals follow the expiry of the lock-in period for Pine Labs’ shares in May. Other investment firms, including Altimeter Capital, Invesco, and Madison India Capital, have also diluted their stakes in the past month. Pine Labs recently reported a consolidated net profit of ₹59.4 crore for the fourth quarter, reversing a loss of ₹28.9 crore a year earlier, with operating revenue rising 14.7% year-on-year to ₹700.5 crore.
For the full fiscal year 2026, Pine Labs posted a profit of ₹112.5 crore. The multiple stake sales by early investors like Actis come as the company transitions from its IPO phase and focuses on strengthening its financial performance, according to inc42.com.